Results of univariable association analysis for respiratory infections (RIs) and BCG exposure status among NMIBC patients participating in the BlaZIB and UroLife studies
| NMIBC BCG | NMIBC no BCG | Unadjusted OR (95% CI) | |||||
| Total | Exposed | Partially exposed | BCG exposed versus no BCG | Partially BCG exposed versus no BCG | BCG versus no BCG | ||
| Total | 407 | 109 | 298 | 250 | – | – | – |
| Pneumonia (%) | 23 (5.7) | 4 (3.7) | 19 (6.4) | 22 (8.8) | 0.40 (0.13 to 1.17) | 0.71 (0.37 to 1.34) | 0.62 (0.34 to 1.14) |
| Bronchitis (%) | 11 (2.7) | 5 (4.6) | 6 (2.0) | 10 (4.0) | 1.15 (0.39 to 3.46) | 0.49 (0.18 to 1.38) | 0.67 (0.28 to 1.59) |
| Laryngitis (%) | 20 (4.9) | 6 (5.5) | 14 (4.7) | 16 (6.4) | 0.85 (0.32 to 2.24) | 0.72 (0.35 to 1.51) | 0.76 (0.38 to 1.49) |
| Influenza (%) | 72 (17.7) | 19 (17.4) | 53 (17.8) | 50 (20.0) | 0.84 (0.47 to 1.51) | 0.87 (0.56 to 1.33) | 0.86 (0.58 to 1.28) |
| Cold (%) | 223 (54.8) | 53 (48.6) | 170 (57.0) | 155 (62.0) | 0.58 (0.37 to 0.91) | 0.81 (0.58 to 1.15) | 0.74 (0.54 to 1.02) |
| All above RIs (%) | 254 (62.4) | 63 (57.8) | 191 (64.1) | 171 (68.4) | 0.63 (0.40 to 1.01) | 0.83 (0.58 to 1.18) | 0.77 (0.55 to 1.07) |
Comparisons were made between NMIBC patients that were considered BCG exposed, partially BCG exposed, and unexposed to BCG (see Methods).
NMIBC, non-muscle invasive bladder cancer.